4474 NEW ZEALAND GAZETTE, No. 151 20 DECEMBER 2012

Malignant Oedema, Black Disease and Sudden Death Syndrome (caused by Clostridium sordellii).

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011.
Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 1024.
Postal Address: PO Box 2825, Shortland Street, Auckland 1140.

Dated at Wellington this 18th day of December 2012.

MAREE ZINZLEY, Manager (Approvals Operations), Ministry for Primary Industries (acting under delegated authority).

go8457

Notice of Application to Register a Trade Name Product (Notice No. MPI 122)

Maree Zinzley, Manager (Approvals Operations) of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Vetoryl
Reference: A010903
Active Concentration and Ingredient: 12.77g/kg Trilostane
Formulation Type: Capsule
General Use Claim: For the treatment of Cushing’s syndrome (excess production of corticosteroids from the adrenal glands) in dogs.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011.
Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

RxVet Limited, Unit 15, 2–4 Northpoint Street, Plimmerton, Porirua 5026.
Postal Address: PO Box 54178, Mana, Porirua 5247.

Dated at Wellington this 18th day of December 2012.

MAREE ZINZLEY, Manager (Approvals Operations), Ministry for Primary Industries (acting under delegated authority).

go8462

Animal Products Act 1999

Notice Under the Animal Products Act 1999 (Notice No. MPI 116)

Pursuant to section 164 of the Animal Products Act 1999, notice is given of the issue on 13 December 2012 of the Animal Products (Contaminant Monitoring and Surveillance) Notice 2012 No. 2, which comes into force on 1 January 2013.

A copy of the notice may be inspected at or obtained at the office of the Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington.

It can also be viewed on the website www.foodsafety.govt.nz

Dated this 14th day of December 2012.

TIM KNOX, Director Market Assurance, Ministry for Primary Industries (acting pursuant to delegated authority).

go8375

Notice Under the Animal Products Act 1999 (Notice No. MPI 118)

Pursuant to section 164 of the Animal Products Act 1999, notice is given of the issue on 14 December 2012 of the Animal Products (National Microbiological Database Specifications) Notice 2012, which comes into force on 7 January 2013.

A copy of the notice may be inspected at or obtained from the office of the Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington.

It can also be viewed on the website www.foodsafety.govt.nz

Dated this 14th day of December 2012.

TIM KNOX, Director Market Assurance, Ministry for Primary Industries (acting pursuant to delegated authority).

go8422

Biosecurity Act 1993

Permission Under Sections 52 and 53 of the Biosecurity Act 1993 (Notice No. MPI 117)

Pursuant to sections 52(d) and 53(2) of the Biosecurity Act 1993, and subject to the conditions set out below,